Evidence map›Paper›PMID 21278219›Full record

ArticleInternational immunology2011

Auto-antibody production and glomerulonephritis in congenic Slamf1-/- and Slamf2-/- [B6.129] but not in Slamf1-/- and Slamf2-/- [BALB/c.129] mice.

Marton Keszei, Yvette E Latchman, Vijay K Vanguri, Daniel R Brown, Cynthia Detre, Massimo Morra, Carolina V Arancibia-Carcamo, Carolina V Arancibia, Elahna Paul, Silvia Calpe and 4 more

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in International immunology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Slamf6 negatively regulates autoimmunity.Clinical immunology (Orlando, Fla.) · 2016
    Article
  6. Article
  7. Roles of CD48 in regulating immunity and tolerance.Clinical immunology (Orlando, Fla.) · 2016
    Review
  8. B cell-intrinsic CD84 and Ly108 maintain germinal center B cell tolerance.Journal of immunology (Baltimore, Md. : 1950) · 2015
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

  • Erratum issued
    Arancibia, Carolina V [corrected to Arancibia-Carcamo, Carolina V]
5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Marton KeszeiDivision of Immunology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA. mkeszei@bidmc.harvard.edu
Yvette E Latchman
Vijay K Vanguri
Daniel R Brown
Cynthia Detre
Massimo Morra
Carolina V Arancibia-Carcamo
Carolina V Arancibia
Elahna Paul
Silvia Calpe
Wilson Castro
Ninghai Wang
Cox Terhorst
Arlene H Sharpe
Harvard University · USBeth Israel Deaconess Medical Center · USBrigham and Women's Hospital · US

Funding

The Slamf3, Slamf5, and Slamf6 receptor-induced pathways to murine lupusP01AI065687 · NIAID · BETH ISRAEL DEACONESS MEDICAL CENTER · PI TERHORST, CORNELIS P · 2006 to 2016
$14.7M
VASCULAR, PULMONARY AND RENAL INJURYT32HL007627 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI GIMBRONE, MICHAEL A, MITCHELL, RICHARD N · 1985 to 2019
$12.7M
NHLBI NIH HHS T32 HL007627NIAID NIH HHS AI-065687NIAMS NIH HHS K08AR05786
6 · The paper itself

Abstract

Several genes in an interval of human and mouse chromosome 1 are associated with a predisposition for systemic lupus erythematosus. Congenic mouse strains that contain a 129-derived genomic segment, which is embedded in the B6 genome, develop lupus because of epistatic interactions between the 129-derived and B6 genes, e.g. in B6.129chr1b mice. If a gene that is located on chromosome 1 is altered through homologous recombination in 129-derived embryonic stem cells (ES cells) and if the resultant knockout mouse is backcrossed with B6, interpretation of the phenotype of the mutant mouse may be affected by epistatic interactions between the 129 and B6 genomes. Here, we report that knockout mice of two adjacent chromosome 1 genes, Slamf1(-/-) and Slamf2(-/-), which were generated with the same 129-derived ES cell line, develop features of lupus, if backcrossed on to the B6 genetic background. By contrast, Slamf1(-/-) [BALB/c.129] and Slamf2(-/-) [BALB/c.129] do not develop disease. Surprisingly, Slamf1(-/-) [B6.129] mice develop both auto-antibodies and glomerulonephritis between 3 and 6 months of age, while disease fully develops in Slamf1(-/-) [B6.129] mice after 9-14 months. Functional analyses of CD4(+) T cells reveals that Slamf2(-/-) T cells are resistant to tolerance induction in vivo. We conclude that the Slamf2(-/-) mutation may have a unique influence on T-cell tolerance and lupus.

Indexed as

AnimalsAntigens, CDAutoantibodiesGlomerulonephritisHumansImmunohistochemistryInbreedingLupus Erythematosus, SystemicMiceMice, 129 StrainMice, CongenicMice, KnockoutReceptors, Cell SurfaceSignaling Lymphocytic Activation Molecule Family Member 1Antigens, CDAutoantibodiesReceptors, Cell SurfaceSignaling Lymphocytic Activation Molecule Family Member 1SLAMF1 protein, humanSlamf1 protein, mouse

Identifiers

PMID21278219
PMCPMC3107444
OpenAlexW2165166037

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.